Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Herpazon
- Development stage
- Unknown
- Lead developer
- Apeks Pharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Herpazon is a topical combination cream containing the antiviral acyclovir (5%) and the corticosteroid hydrocortisone (1%). Marketed by Apeks Pharma and manufactured by İlko İlaç, it is indicated for the treatment of herpes simplex virus (HSV) skin infections, particularly herpes labialis (cold sores). Acyclovir acts as a nucleoside analogue that inhibits viral DNA polymerase, thereby preventing viral replication. Hydrocortisone, a low-potency corticosteroid, acts as a glucocorticoid receptor agonist to provide anti-inflammatory effects, reducing the erythema and edema associated with herpes lesions. This dual-action approach aims to both treat the underlying viral infection and alleviate the inflammatory symptoms associated with the outbreak.
- Brand names
- Herpazon
02
Targets
DNA polymerase familyGR (Glucocorticoid receptor)
Beyond the preview
Go deeper on Herpazon.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Herpazon.